July 27, 2008 11:26 PM
- Text
The Incredible Shrinking Pharma Industry
It's not just layoffs anymore. The market-research firm Industrial Info Resources notes in a recent report that pharma plans to shutter 26 plants and research facilities across North America, in addition to the tens of thousands of sales reps, scientists and manufacturing-plant workers big drugmakers are letting go. Those closures also follow the shutdown (or notification thereof) of 77 other industry sites since 2007, which together employed 14,000 people.From Pharmalot's Ed Silverman, who apparently shelled out $9.95 for the full report:
Among the 26 that are still scheduled to be shuttered is an AstraZeneca facility in Ontario; a pair of Biovail plants in Puerto Rico; a Bristol-Myers Squibb facility in Puerto Rico, and a Barr Pharmaceuticals plant in New Jersey. And here's another Biovail plant that will go.Smoking in bed while the house is on fire, indeed. The World of DTC Marketing blog concurs:
"Some of the plants targeted for closure will undoubtedly be reopened by others. With companies eager to shed the buildings, and often the equipment inside, some good deals come on the market--Others, like Pfizer in Michigan, are donating buildings and equipment to local colleges, universities and economic development boards to bolster education and, ironically, new job creation for emerging companies," according to IIR.
Marketing budgets are being cut by blue chip marketers, DTC budgets are being cut and if you think this is the worst "you ain't seen nothing yet!" With the pharma industry in black hole of transition to new business models that will finally work and Genentech blind sided by Roche's bid to buy the whole company many marketing people had better start updating their resumes as rumored deep cuts in marketing may finally become a reality with an industry struggling to be profitable and develop new drugs....Image via Flickr user Keith JM G, CC 2.0
What is so sad is that pharma's addiction to blockbusters is partially responsible for this mess. With the huge revenues of these products pharma could spend money like a drunk monkey in a banana store. However the dark side is that blockbusters lead to an addiction for more blockbusters and they don't appear out of thin air. Fasten your seat belt it's going to get a lot more bumpy.
-
David Hamilton is the assistant managing editor of CNET News. He has been writing and editing business and tech coverage for about two decades -- the majority of that at the Wall Street Journal in both Tokyo and San Francisco.
Follow on Twitter »
Add A Comment +
Popular Now in MoneyWatch
- Report: Zuckerberg drops off 40 richest list
- What are the most dangerous websites?
- Facebook shares close at new low
- 10 Best Countries To Live and Work Abroad
- 5 reasons to invest in a 529 plan
- Average home prices hit mid-2002 levels
- 4 Things Not to Buy at Costco
- Top 10 Cities for Single Men
- How to craft an email that gets a reply
- Used Cars: 5 to Avoid (and 5 Better Alternatives)
- The 7 Interview Questions You Must Ask
- Why leaders should scowl
- Reverse Cell Phone Lookup Service is Free and Simple
- Law firm Dewey & LeBoeuf files for bankruptcy
- Radioactive bluefin tuna crossed the Pacific to US
- Why renters should consider buying a home






